FBN33428

• CAT Number: I027301
• CAS Number: 206133-42-8
• Molecular Formula: C42H48N4O7
• Molecular Weight: 720.87
• Purity: 98%
• Synonyms: Fmoc-​Phe-​Lys(Boc)​-​PAB; FBN33428; FBN-33428; FBN 33428
• Target: ADC Linker
• Solubility: To be determined
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: tert-butyl N-[(5S)-5-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-phenylpropanoyl]amino]-6-[4-(hydroxymethyl)anilino]-6-oxohexyl]carbamate
• InChI: InChI=1S/C42H48N4O7/c1-42(2,3)53-40(50)43-24-12-11-19-36(38(48)44-30-22-20-29(26-47)21-23-30)45-39(49)37(25-28-13-5-4-6-14-28)46-41(51)52-27-35-33-17-9-7-15-31(33)32-16-8-10-18-34(32)35/h4-10,13-18,20-23,35-37,47H,11-12,19,24-27H2,1-3H3,(H,43,50)(H,44,48)(H,45,49)(H,46,51)/t36-,37-/m0/s1
• InChIKey: FSNKYAMDHPYUFM-BCRBLDSWSA-N
• SMILES: CC(C)(C)OC(=O)NCCCC[C@@H](C(=O)NC1=CC=C(C=C1)CO)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35

FBN33428（Cat No.:I027301）is a novel investigational compound being studied for its potential therapeutic effects in treating neurological and autoimmune conditions. It acts by modulating key signaling pathways in immune cells, particularly targeting receptors involved in inflammatory responses. Research suggests that FBN33428 may reduce the activation of pro-inflammatory cytokines and provide neuroprotective benefits, making it a potential candidate for diseases like multiple sclerosis and rheumatoid arthritis. Preclinical studies have shown promising results, and ongoing clinical trials are focused on assessing its safety, efficacy, and optimal dosing to determine its future role in treatment regimens.